SYDNEY WENTZ: Open Payments
NPI 1497425250 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,309 in 72 payments from 20 companies in 2025. Trend: 2023 $705 · 2024 $948 · 2025 $1,309
Food & beverage: $1,209Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $224 |
| Janssen Biotech, Inc. | 8 | $196 |
| PFIZER INC. | 7 | $118 |
| UCB, Inc. | 5 | $117 |
| CORDIS US CORP. | 1 | $110 |
| Novartis Pharmaceuticals Corporation | 4 | $108 |
| Lilly USA, LLC | 4 | $91 |
| GENZYME CORPORATION | 2 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $43 |
Products named: SKYRIZI, TREMFYA, CIBINQO, Bimzelx, MYNX CONTROL VENOUS, COSENTYX, DUPIXENT, TALTZ.
Industry payments across AZ — which companies pay providers there.
